Digital Health Market Key Drivers, Trends and Emerging Opportunities
FAQ's
Answer : According to Precedence Research, the global paclitaxel injection market size was reached at US$ 4.51 billion in 2021 and is expected to hit over US$ 11.16 billion by 2030.
Answer : The global paclitaxel injection market is projected to grow at a noteworthy CAGR of 12.5% from forecast period 2022 to 2030.
Answer : Breast Cancer segment displayed the major share in the global paclitaxel injection market in 2020. High incidence of breast cancer globally and high investment in the development of effective breast cancer treatment are the key reason for highest market stake of breast cancer.
Answer : In 2020, the North American region dominated the worldwide market with a market share of higher than 40%.
Answer : Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers, high prevalence of cancer, and growing per-capita healthcare expenditure.
Answer : The key companies functioning in the worldwide paclitaxel injection market are Celgene Corporation, Sagent Pharmaceuticals, Abbott Laboratories, Bristol Myers Squibb, Fresenius Kabi Oncology Ltd, Luye Pharma Group, Onco Therapies Ltd (Strides Arcolab Ltd.), NOVASEP, and Pfizer among others.
Answer : Some of the major reasons driving the growth of paclitaxel injection market are growing incidence of cancer worldwide, better efficiency of paclitaxel over other preparations in cancer treatment, ease of availability, increasing expenditure by major companies on research and development for advance of more effective paclitaxel injection, launch of new products, and increasing per capita healthcare spending in developing regions.
Get a Sample of this Report
Digital Health Market
